Corporate Sponsors

ASCEND CLINICAL
Privately held Ascend Clinical, LLC is the nation's leading provider of ESRD laboratory testing and electronic reporting for independent and hospital-based dialysis facilities. Headquartered in Redwood City, CA, with 23 field offices and a product development office in Denver, CO, the company was named one of the Bay Area's Top Workplaces in 2010. Ascend Clinical serves independent dialysis providers throughout the 50 United States and territories.

For more information, visit www.ascendclinical.com.

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.

ARDELYX

Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA^® (tenapanor) and XPHOZAH^® (tenapanor) as well as early-stage pipeline candidates. Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin has received approval for PHOZEVEL^® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been submitted in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. For more information, please visit https://ardelyx.com/ and connect with us on X (formerly known as Twitter), LinkedIn and Facebook.

FRESENIUS MEDICAL CARE
Fresenius Medical Care is not your typical medical products company. We are a close-knit team of talented professionals driven by a shared commitment: to lead a movement to dramatically improve renal care with innovative yet simple therapeutic solutions that benefit patients, caregivers, and society. We pursue this goal through a passionate commitment to Innovate, Educate and Advocate for the breakthroughs that are redefining renal care. Additionally, Fresenius works in community with its customers, patients, industry partners, and government leaders and agencies to realize the vision of better, simpler, more accessible renal care.

For more information, please visit fmcna.com.

BAXTER
Baxter International Inc. Renal business is a leader in renal home therapies through its products for peritoneal dialysis (PD), providing solutions, devices and services for end-stage kidney disease patients. Baxter also distributes products for in-center hemodialysis. 

Visit www.homebybaxter.com to learn more about home therapies.

CSL VIFOR 

CSL Vifor is a global pharmaceutical company that researches, develops, produces and markets its own pharmaceutical products.  Poised to be a global leader in iron deficiency, nephrology and cardio-renal therapies, Vifor strives to help patients around the world with severe and chronic diseases to lead better, healthier lives.

For more information, please visit www.viforpharma.com.

DIALITY

Diality is developing a smart, versatile hemodialysis system designed to be as capable as in-center systems while also easy to learn and use in any chronic or acute dialysis environment. The Diality system offers flexibility to tailor treatment to each patient’s specific needs, regardless of modality and care setting, and empowers kidney care providers to choose what is right for their patients and practices during this time of unprecedented change in the care of patients with kidney disease.

For more information, visit https://www.diality.com/.

NATIONAL DIALYSIS ACCREDITATION COMMISSION

National Dialysis Accreditation Commission is an Accreditation Organization (AO) specializing in the dialysis industry. NDAC was the first AO in the U.S. to be approved by CMS for deemed status for End State Renal Disease. Dialysis providers successfully completing NDAC's accreditation process can be awarded Medicare certification from CMS based on their accreditation with recommendation for deemed status by NDAC. Based in Glen Ellyn, Illinois, NDAC offers accreditation services in all 50 United States and U.S. territories. NDAC's owners and executive leadership are experts and thought leaders with a long track record of success in ESRD, which is why NDAC provides Dialysis Accreditation by Dialysis Experts©. 

For more information about NDAC, please visit www.ndacommission.com/. 

NEPHROLOGY NEWS & ISSUES
Nephrology News & Issues is a peer-reviewed national news magazine that takes a global approach to covering the political, social, and economic issues surrounding the delivery of dialysis and transplant care. The magazine's website, www.healio.com/nephrology, provides daily updates on healthcare news that impacts renal care.

All Renal Healthcare Association Members receive a free subscription to the magazine.

.